Recent findings Recent studies on over 13 000 healthy blood donors, as part of the Recipient Epidemiology and Donor Evaluation Study (REDS) III and IV-P RBC omics, and 525 diversity outbred mice have highlighted the impact on RBC metabolism of biological factors (age, BMI), genetics (sex, polymorphisms) and exposure (dietary, professional or recreational habits, drugs that are not grounds for blood donor deferral)
These drugs have tremendous benefit, but more ongoing studies are needed outside of patients with diabetes, obesity, and metabolic disease before we can apply safely, says Srinath
La optimizacin de la dosis es otra estrategia importante
and 8,783 and 35,532 people, respectively, in the T2D with CKD cohort